# Effects of Continuous Positive Airway Pressure (CPAP) on Glucose Metabolism

Study · id `cardio:ct-nct01503164` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01503164](<https://clinicaltrials.gov/study/NCT01503164>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01503164

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 111 participants.

## Technical summary

Registry record NCT01503164. Randomized; no masking; primary purpose treatment. Start 2011-09 (actual); primary completion 2013-12 (actual). Results posted on 2017-10-19.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 111 participants (enrolled count; ClinicalTrials.gov record NCT01503164, source copy `cardio:ctgov-nct01503164-2017-10-19`, retrieved 2026-10-26)
- Started: 2011-09 (actual) (ClinicalTrials.gov record NCT01503164, source copy `cardio:ctgov-nct01503164-2017-10-19`, retrieved 2026-10-26)
- Primary completion: 2013-12 (actual) (ClinicalTrials.gov record NCT01503164, source copy `cardio:ctgov-nct01503164-2017-10-19`, retrieved 2026-10-26)
- Completion: 2013-12 (actual) (ClinicalTrials.gov record NCT01503164, source copy `cardio:ctgov-nct01503164-2017-10-19`, retrieved 2026-10-26)
- Results first posted: 2017-10-19 (ClinicalTrials.gov record NCT01503164, source copy `cardio:ctgov-nct01503164-2017-10-19`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT01503164, source copy `cardio:ctgov-nct01503164-2017-10-19`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01503164-2017-10-19`, retrieved 2026-10-26)

## The registry's words

- Brief title: Effects of Continuous Positive Airway Pressure (CPAP) on Glucose Metabolism
- Acronym: SOMNOS
- Condition: Obstructive Sleep Apnea
- Condition: Sleep Apnea
- Condition: Sleep-disordered Breathing
- Intervention (Device): Positive Pressure Therapy (PAP)
- Intervention (Behavioral): LifeStyle Counseling
- Lead sponsor: Johns Hopkins University
- Lead sponsor class: OTHER
- Collaborator: National Heart, Lung, and Blood Institute (NHLBI)
- Collaborator class: NIH

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: Johns Hopkins University (`cardio:org-johns-hopkins-university`)
- Registry lists this organization as a collaborator: National Heart, Lung, and Blood Institute (`cardio:nhlbi`)

## Provenance

Content hash: 41c4966865df26a382166e8cb10ed5b21fb4780088b6105bd1ac67476c5da82f
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
